Hematocrit 47.2% Assessment
A hematocrit of 47.2% falls within the normal physiological range for adult males and postmenopausal females (47 ± 6%), but is mildly elevated for premenopausal women (normal 41 ± 5%); no immediate intervention is required, but the value should be interpreted in the context of sex, altitude, and clinical symptoms. 1, 2
Normal Reference Ranges by Sex and Age
For adult males and postmenopausal females:
For premenopausal (menstruating) females:
Your value of 47.2% is:
- Normal for males/postmenopausal females 2
- Mildly elevated (approximately 95th percentile) for premenopausal women 1
Altitude Adjustment Required
If you live at altitude ≥3,000 feet (914 meters), your hematocrit should be interpreted with upward adjustment: 3
- At 1,500 meters: add +0.5 g/dL to hemoglobin (approximately +1.5% to hematocrit) 1, 3
- At 2,000 meters: add +0.8 g/dL to hemoglobin (approximately +2.4% to hematocrit) 1, 3
- At 4,000 meters: normal male hematocrit averages 52.7% (range 45–61%) 4
Failure to adjust for altitude leads to overdiagnosis of polycythemia and underdiagnosis of anemia. 3
When to Investigate Further
Repeat measurement is warranted if: 1
- You are a premenopausal woman (47.2% exceeds typical female range) 1, 2
- You have symptoms of hyperviscosity (headache, blurred vision, confusion, bleeding) 1
- You have documented progressive rise over 6 months 1
- You have thrombocytosis, leukocytosis, or splenomegaly 1
Initial laboratory workup should include: 1
- Complete blood count with red cell indices (MCV, MCH, MCHC, RDW) 1
- Serum ferritin and transferrin saturation (iron deficiency can coexist with erythrocytosis) 1
- Reticulocyte count 1
- White blood cell differential and platelet count 1
Diagnostic Thresholds for True Erythrocytosis
True erythrocytosis requiring JAK2 mutation testing is defined as: 1
Your value of 47.2% does NOT meet these thresholds for mandatory polycythemia vera workup. 1
When Phlebotomy Is Indicated
Therapeutic phlebotomy is indicated ONLY when ALL of the following are present: 1
- Hemoglobin >20 g/dL AND hematocrit >65% 1
- Documented hyperviscosity symptoms 1
- Adequate hydration confirmed 1
- Iron deficiency excluded 1
Your value of 47.2% is far below the 65% threshold; phlebotomy is NOT indicated and would be harmful. 1
Clinical Significance of Borderline-High Hematocrit
Even hematocrit values in the high-normal range (45–49%) are associated with increased cardiovascular risk: 5
- In the Framingham Heart Study, hematocrit >45% (compared to <40%) was associated with a 78% increased risk of developing heart failure over 20 years (HR 1.78,95% CI 1.15–2.75) 5
- This association persisted after adjusting for cardiovascular risk factors and remained significant in nonsmokers 5
However, in chronic kidney disease, hematocrit 33–36% is associated with 10% reduced mortality compared to 30–33%, suggesting context-dependent optimal ranges. 2, 6
Recommended Follow-Up
For asymptomatic individuals with hematocrit 47.2%: 1
- If male or postmenopausal female at sea level: No immediate action required; routine monitoring 2
- If premenopausal female: Repeat measurement to confirm; if persistent, obtain complete blood count with indices and iron studies 1
- If living at altitude ≥3,000 feet: Apply altitude adjustment before determining if value is abnormal 3
- Serial measurements every 6–12 months are appropriate for borderline values to detect progression 1
Common Pitfalls to Avoid
Do not perform phlebotomy for hematocrit <65% without documented hyperviscosity symptoms and adequate hydration. 1
Do not overlook coexisting iron deficiency—serum ferritin and transferrin saturation must be checked, as iron deficiency mimics hyperviscosity but requires iron supplementation, not phlebotomy. 1
Do not use sea-level reference ranges for patients living at altitude ≥3,000 feet—this leads to misdiagnosis. 3
Hemoglobin is more reliable than hematocrit for monitoring because hematocrit can falsely increase 2–4% with prolonged sample storage, while hemoglobin remains stable. 1, 2